Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 3
2005 1
2006 4
2007 7
2008 3
2009 6
2010 5
2011 9
2012 10
2013 6
2014 4
2015 5
2016 12
2017 7
2018 4
2019 2
2020 10
2021 10
2022 3
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Development of NP-Based Universal Vaccine for Influenza A Viruses.
Sayedahmed EE, Elshafie NO, Dos Santos AP, Jagannath C, Sambhara S, Mittal SK. Sayedahmed EE, et al. Among authors: sambhara s. Vaccines (Basel). 2024 Feb 2;12(2):157. doi: 10.3390/vaccines12020157. Vaccines (Basel). 2024. PMID: 38400140 Free PMC article.
Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines.
Liu F, Gross FL, Joshi S, Gaglani M, Naleway AL, Murthy K, Groom HC, Wesley MG, Edwards LJ, Grant L, Kim SS, Sambhara S, Gangappa S, Tumpey T, Thompson MG, Fry AM, Flannery B, Dawood FS, Levine MZ. Liu F, et al. Among authors: sambhara s. Nat Commun. 2024 Jan 4;15(1):254. doi: 10.1038/s41467-023-44551-x. Nat Commun. 2024. PMID: 38177116 Free PMC article. Clinical Trial.
Immunogenicity of High-Dose Egg-Based, Recombinant, and Cell Culture-Based Influenza Vaccines Compared With Standard-Dose Egg-Based Influenza Vaccine Among Health Care Personnel Aged 18-65 Years in 2019-2020.
Naleway AL, Kim SS, Flannery B, Levine MZ, Murthy K, Sambhara S, Gangappa S, Edwards LJ, Ball S, Grant L, Zunie T, Cao W, Gross FL, Groom H, Fry AM, Hunt D, Jeddy Z, Mishina M, Wesley MG, Spencer S, Thompson MG, Gaglani M, Dawood FS. Naleway AL, et al. Among authors: sambhara s. Open Forum Infect Dis. 2023 Apr 21;10(6):ofad223. doi: 10.1093/ofid/ofad223. eCollection 2023 Jun. Open Forum Infect Dis. 2023. PMID: 37305842 Free PMC article.
Antiviral Approaches against Influenza Virus.
Kumari R, Sharma SD, Kumar A, Ende Z, Mishina M, Wang Y, Falls Z, Samudrala R, Pohl J, Knight PR, Sambhara S. Kumari R, et al. Among authors: sambhara s. Clin Microbiol Rev. 2023 Mar 23;36(1):e0004022. doi: 10.1128/cmr.00040-22. Epub 2023 Jan 16. Clin Microbiol Rev. 2023. PMID: 36645300 Free PMC article. Review.
Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial.
Gaglani M, Kim SS, Naleway AL, Levine MZ, Edwards L, Murthy K, Dunnigan K, Zunie T, Groom H, Ball S, Jeddy Z, Hunt D, Wesley MG, Sambhara S, Gangappa S, Grant L, Cao W, Gross FL, Mishina M, Fry AM, Thompson MG, Dawood FS, Flannery B. Gaglani M, et al. Among authors: sambhara s. Clin Infect Dis. 2023 Feb 8;76(3):e1168-e1176. doi: 10.1093/cid/ciac683. Clin Infect Dis. 2023. PMID: 36031405 Free PMC article. Clinical Trial.
Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults.
Spencer S, Chung JR, Belongia EA, Sundaram M, Meece J, Coleman LA, Zimmerman RK, Nowalk MP, Moehling Geffel K, Ross T, Carter CE, Shay D, Levine M, Liepkalns J, Kim JH, Sambhara S, Thompson MG, Flannery B. Spencer S, et al. Among authors: sambhara s. Influenza Other Respir Viruses. 2022 May;16(3):562-567. doi: 10.1111/irv.12933. Epub 2021 Dec 3. Influenza Other Respir Viruses. 2022. PMID: 34859584 Free PMC article.
114 results